Corecam AG’s Pfizer PFE Stock Holding History

Corecam AG’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.96M	Buy	164,350 +260	+0.2%	+$6.8K	3.38%	7
2026 Q1	$4.61M	Hold	164,090	–	–	3.93%	9
2025 Q4	$4.09M	Buy	+164,090	New	+$4.14M	3.99%	7

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Corecam AG's PFE Position: Q2 2026 in Review

Corecam AG increased its Pfizer (PFE) stake by 0.16% in Q2 2026, buying an estimated $6.8K and bringing the position to 164,350 shares worth $3.96M. The position accounts for 3.38% of the portfolio, ranked #7.

Corecam AG first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.61M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Corecam AG held 164,350 shares of Pfizer worth $3.96M as of Q2 2026.
Corecam AG bought 260 Pfizer shares in Q2 2026, an estimated $6.8K.
Pfizer made up 3.38% of Corecam AG's portfolio in Q2 2026, its #7 holding.
Corecam AG first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
Corecam AG's Pfizer position peaked at $4.61M in Q1 2026.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Corecam AG's 13F filing for Q2 2026, filed 17 Jul 2026.